JASCAYD 9 mg, film-coated tablet tablet
Active ingredients: NÉRANDOMILAST
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablettabletorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- JASCAYD 9 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- Plaquettes prédécoupées unitaires PVC-Aluminium de 60 x 1 comprimé
- Marketing authorisation holder
- BOEHRINGER INGELHEIM INTERNATIONAL
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 21 Sept 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
61386673CIP73034274CIP133400930342749Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| NÉRANDOMILASTcomprimé | 9 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.